PAX2 and chronic kidney disease: Clinicians must be more alert for <i>PAX2</i> mutation when facing patients with congenital kidney and urinary tract anomalies, chronic kidney disease of unknown etiology, involvement of multiple systems, and/or a family history of renal disease.